The aim of the present study was to evaluate the risk factors for postoperative complications following liver resection for colorectal cancer liver metastases. Patients who underwent hepatic resection for colorectal cancer liver metastases were stratified according to chemotherapy administration and body mass index (BMI) to eliminate potential confounding factors. A univariate analysis was conducted to identify potential risk factors for postoperative complications following liver resection. Variables that exhibited a potential association were evaluated by multivariable logistic regression analysis to identify those independently associated with postoperative morbidity. Between January 2012 and March 2012, 100 patients underwent hepatic re...
OBJECTIVE: To assess the impact of microsteatosis (MiS) and macrosteatosis (MaS) on major hepatectom...
Trabalho final de mestrado integrado em Medicina (Cirurgia Geral), apresentado á Faculdade de Medici...
BACKGROUND Chemotherapy-associated liver injury is a major cause for concern when treating patients ...
The aim of the present study was to evaluate the risk factors for postoperative complications follow...
Purpose Chemotherapy before resection of hepatic colorectal metastases (CRM) may cause hepatic injur...
AbstractBackgroundHepatic steatosis, a common condition associated with insulin resistance and exces...
Objective: Surgical resection is the mainstay treatment for colorectal liver metastasis. In unresect...
BACKGROUND: New systemic chemotherapy agents have improved prognosis in patients with colorectal liv...
BACKGROUND: Obesity and tissue adiposity constitute a risk factor for several cancers. Whether tissu...
Background: Preoperative systemic chemotherapy is increasingly used in patients who undergo hepatic ...
Background: The risk of major hepatic resection in patients with hepatic steatosis remains controver...
[eng] Background and objectives Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy...
Partial liver resections are the treatment of choice for patients with a malignant liver or bile duc...
BACKGROUND: The impact of chemotherapy-associated liver injury (CALI) on postoperative outcome in pa...
BACKGROUND: In spite of accurate selection of patients eligible for resection, and although advances...
OBJECTIVE: To assess the impact of microsteatosis (MiS) and macrosteatosis (MaS) on major hepatectom...
Trabalho final de mestrado integrado em Medicina (Cirurgia Geral), apresentado á Faculdade de Medici...
BACKGROUND Chemotherapy-associated liver injury is a major cause for concern when treating patients ...
The aim of the present study was to evaluate the risk factors for postoperative complications follow...
Purpose Chemotherapy before resection of hepatic colorectal metastases (CRM) may cause hepatic injur...
AbstractBackgroundHepatic steatosis, a common condition associated with insulin resistance and exces...
Objective: Surgical resection is the mainstay treatment for colorectal liver metastasis. In unresect...
BACKGROUND: New systemic chemotherapy agents have improved prognosis in patients with colorectal liv...
BACKGROUND: Obesity and tissue adiposity constitute a risk factor for several cancers. Whether tissu...
Background: Preoperative systemic chemotherapy is increasingly used in patients who undergo hepatic ...
Background: The risk of major hepatic resection in patients with hepatic steatosis remains controver...
[eng] Background and objectives Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy...
Partial liver resections are the treatment of choice for patients with a malignant liver or bile duc...
BACKGROUND: The impact of chemotherapy-associated liver injury (CALI) on postoperative outcome in pa...
BACKGROUND: In spite of accurate selection of patients eligible for resection, and although advances...
OBJECTIVE: To assess the impact of microsteatosis (MiS) and macrosteatosis (MaS) on major hepatectom...
Trabalho final de mestrado integrado em Medicina (Cirurgia Geral), apresentado á Faculdade de Medici...
BACKGROUND Chemotherapy-associated liver injury is a major cause for concern when treating patients ...